MARATTO

article · Current Topics in Medicinal Chemistry

Plant-Derived Pathway Modulators: A Natural Strategy to Combat Cervical Cancer

Abstract

Cervical Cancer (CC) is a significant global health concern due to its high death rate, necessitating the development of effective therapeutic, diagnostic, and preventative substances. The current treatment methods for advanced metastatic CC include surgery, radiotherapy, and chemotherapy. Plants and phytocompounds have emerged as promising options for preventing CC. This review provides a comprehensive overview of the molecular mechanisms by which various phytocompounds exert their anticancer properties. It explores the impact of key signaling pathways, molecular interactions, and substances on metastasis inhibition, cell cycle control, and apoptosis. Additionally, it presents promising preclinical and clinical findings highlighting the potential of phytochemicals as adjuvant therapy in standard CC treatment. This summary highlights the effectiveness and well-tolerated potential of plant-based interventions and phytocompounds in CC therapy. Furthermore, it demonstrates the therapeutic potential of phytochemicals in CC, integrating molecular biology with clinical evidence and paving the way for further research and clinical applications. This review aims to advance innovative treatment methodologies for CC prophylaxis and therapy, emphasizing the need for further research into plant-based treatments to enhance patient outcomes.

Research topics

  • Flavonoids in Medical Research
  • Toxin Mechanisms and Immunotoxins
  • Cancer Mechanisms and Therapy

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2174/0115680266411142251201065848

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.